Early Markers in Parkinson’s and Alzheimer’s Diseases: New Vistas in Drug Research, cartea 1
Editat de Philippe Dostert, Peter Riederer, Margherita Strolin Benedetti, Romeo Roncuccien Limba Engleză Paperback – 9 ian 2012
Preț: 362.60 lei
Preț vechi: 381.68 lei
-5% Nou
Puncte Express: 544
Preț estimativ în valută:
69.39€ • 72.100$ • 57.60£
69.39€ • 72.100$ • 57.60£
Carte tipărită la comandă
Livrare economică 16-30 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783709191002
ISBN-10: 3709191009
Pagini: 310
Ilustrații: XX, 310 p.
Dimensiuni: 152 x 229 x 32 mm
Greutate: 0.45 kg
Ediția:Softcover reprint of the original 1st ed. 1990
Editura: SPRINGER VIENNA
Colecția Springer
Seria New Vistas in Drug Research
Locul publicării:Vienna, Austria
ISBN-10: 3709191009
Pagini: 310
Ilustrații: XX, 310 p.
Dimensiuni: 152 x 229 x 32 mm
Greutate: 0.45 kg
Ediția:Softcover reprint of the original 1st ed. 1990
Editura: SPRINGER VIENNA
Colecția Springer
Seria New Vistas in Drug Research
Locul publicării:Vienna, Austria
Public țintă
ResearchCuprins
Early markers in Parkinson’s disease.- Early markers in Parkinson’s disease.- Differential diagnosis of Parkinson’s disease.- The premorbid personality of patients with Parkinson’s disease.- An antibody in the CSF of Parkinson’s disease patients: summary of data and potential role as a diagnostic marker.- Contribution of motor performance tests to the early diagnosis of Parkinson’s disease.- Electrophysiological methods in the early diagnosis of Parkinson’s disease.- Characterization of Parkinson’s disease using positron emission tomography.- Dopamine beta-hydroxylase and beta 2-microglobulin in cerebrospinal fluid: early markers in Parkinson’s disease.- Urinary dopamine sulfate conjugates in Parkinson’s disease.- Salsolinol and the early detection of Parkinson’s disease.- MR imaging of putamenal iron predicts response to dopaminergic therapy in parkinsonian patients.- The neurotoxic component in Parkinson’s disease may involve iron-melanin interaction and lipid peroxidation in the substantia nigra.- Round table on Parkinson’s disease.- Early markers in Alzheimer’s disease.- The need for early markers in Alzheimer’s disease.- Descriptive and analytic epidemiology of Alzheimer’s disease.- Differential diagnosis of early Alzheimer’s disease.- Down syndrome: a model for the study of Alzheimer’s disease and aging.- PET scanning for the detection of Alzheimer’s disease.- Reference-free evaluation of auditory evoked potentials—P300 in aging and dementia.- Enzymes and glial cells in brain damage and neurodegenerative diseases.- Senile dementia of Alzheimer’s type and Parkinson’s disease: neurochemical overlaps and specific differences.- Changes in brain energy metabolism and the early detection of Alzheimer’s disease.- Cholinemetabolism in Alzheimer’s disease: hints as to possible markers.- The presence of antibrain antibodies in the CSF of some Alzheimer disease patients: correlation with CSF parameters.- Increased monoamine oxidase activity and vitamin B-12 deficiency in dementia disorders.- Round table on Alzheimer’s disease.- Closing remarks.